简体中文 | 繁體中文 | English

Products & Services News

2018-10-24 17:53 VIB 9–month profit before tax rises 176% YoY to VND 1,720 billion, Retail revenue increases 92% YoY
2018-10-24 16:41 CNIM Presents a Rapid Version of The LCAT® Shore-to-Shore Featuring Unique Operational Capabilities
2018-10-24 16:39 Visa Brings a Simpler, Safer Experience to Digital Payments
2018-10-24 16:32 Malta and Austria Are Home to the World’s Best Investment Migration Programs
2018-10-24 13:00 Gemalto Celebrates 100 eSIM Solutions Deployed Worldwide
2018-10-24 10:13 NewCity Digital Partners with Forbes Media, NewCity Capital and trade.io to Launch Forbes CryptoMarkets
2018-10-24 10:09 IWBI Launches Global Network of Advisors for WELL Portfolio
2018-10-24 10:03 Power Integrations Unveils High-Efficiency Flyback Switcher ICs with Integrated 900 V MOSFETs
2018-10-24 09:58 Active-Semi’s New PMICs Reduce Size and Increase Power Density with Leading Field Programable Technology
2018-10-24 09:46 New Nordson EFD Fluid Dispensing Video Gallery is Now Live
2018-10-23 18:21 SmartStream Steps Ahead with New Industry Digital Payments Solution
2018-10-23 18:00 Enevate Secures Funding from LG Chem to Accelerate Fast Charge Li-Ion Battery Technology Development for Electric Vehicles
2018-10-23 15:19 DataCo and SES Networks to Provide Broadband Network for APEC 2018
2018-10-23 15:05 Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
2018-10-23 10:53 Philip Morris International Launches Next Generation of IQOS, the World’s Leading Heated Tobacco Product
2018-10-23 10:13 Sony Corporation Selects ANAQUA for IP Management
2018-10-23 10:11 Smart Link Accelerates Digital Service Expansion with Avaya Cloud Contact Center Solutions
2018-10-22 16:20 Outline of New ESMO Guidelines Indicates Inclusion of FOTIVDA®▼ (Tivozanib) for Patients with Advanced Renal Cell Carcinoma
2018-10-22 14:45 Manchester United and True Religion Launch Denim Range
2018-10-22 13:40 Investigational Subcutaneous Formulation of Vedolizumab Achieves and Maintains Clinical Remission and Mucosal Healing at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis

Business Wire Weibo

Press Releases

Latest Releases